Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jørgensen, Marit Eika"'
Autor:
Færch K; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark., Amadid H; Steno Diabetes Center Copenhagen, Gentofte, Denmark., Bruhn L; Steno Diabetes Center Copenhagen, Gentofte, Denmark., Clemmensen KKB; Steno Diabetes Center Copenhagen, Gentofte, Denmark., Hulman A; Steno Diabetes Center Aarhus, Aarhus, Denmark., Ried-Larsen M; Centre for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark.; Institute of Sports and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark., Blond MB; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark., Jørgensen ME; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; University of Southern Denmark, Copenhagen, Denmark., Vistisen D; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Oct 05; Vol. 12, pp. 753810. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Autor:
Hansen CS; Steno Diabetes Center Copenhagen, Gentofte, Denmark christian.stevns.hansen@regionh.dk., Færch K; Steno Diabetes Center Copenhagen, Gentofte, Denmark., Jørgensen ME; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; National Institute of Public Health, Southern Denmark University, Odense, Denmark., Malik M; National Heart and Lung Institute, Imperial College, London, U.K., Witte DR; Department of Public Health, Aarhus University, Aarhus, Denmark.; Danish Diabetes Academy, Odense, Denmark., Brunner EJ; Department of Epidemiology and Public Health, University College London, London, U.K., Tabák AG; Department of Epidemiology and Public Health, University College London, London, U.K.; Faculty of Medicine, Semmelweis University, Budapest, Hungary., Kivimäki M; Department of Epidemiology and Public Health, University College London, London, U.K., Vistisen D; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Publikováno v:
Diabetes care [Diabetes Care] 2019 May; Vol. 42 (5), pp. 867-874. Date of Electronic Publication: 2019 Apr 02.
Autor:
Færch K; Steno Diabetes Center Copenhagen, 2820 Gentofte, Denmark., Witte DR; Department of Public Health, Aarhus University, 8000 Aarhus, Denmark.; Danish Diabetes Academy, 5000 Odense, Denmark., Brunner EJ; Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom., Kivimäki M; Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom., Tabák A; Department of Epidemiology and Public Health, University College London, London WC1E 6BT, United Kingdom.; First Department of Medicine, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary., Jørgensen ME; Steno Diabetes Center Copenhagen, 2820 Gentofte, Denmark.; National Institute of Public Health, Southern Denmark University, 1353 Copenhagen, Denmark., Ekelund U; Department of Sport Medicine, Norwegian School of Sport Sciences, 0806 Oslo, Norway.; Norwegian Institute of Public Health, 0403 Oslo, Norway., Vistisen D; Steno Diabetes Center Copenhagen, 2820 Gentofte, Denmark.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2017 Oct 01; Vol. 102 (10), pp. 3712-3721.
Autor:
Kosiborod M; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.). mkosiborod@saint-lukes.org., Cavender MA; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Fu AZ; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Wilding JP; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Khunti K; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Holl RW; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Norhammar A; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Birkeland KI; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Jørgensen ME; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Thuresson M; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Arya N; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Bodegård J; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Hammar N; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.)., Fenici P; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K.K.); University of Ulm, Germany (R.W.H.); Karolinska Institutet, Stockholm, Sweden (A.N., N.H.); University of Oslo, Norway (K.I.B.); Oslo University Hospital, Norway (K.I.B.); Steno Diabetes Center, Copenhagen, Gentofte, Denmark (M.E.J.); National Institute of Public Health, Southern Denmark University, Copenhagen (M.E.J.); Statisticon AB, Uppsala, Sweden (M.T.); AstraZeneca, Gaithersburg, MD (N.A.); AstraZeneca, Oslo, Norway (J.B.); AstraZeneca Gothenburg, Sweden (N.H.); and AstraZeneca, Cambridge, United Kingdom (P.F.).
Publikováno v:
Circulation [Circulation] 2017 Jul 18; Vol. 136 (3), pp. 249-259. Date of Electronic Publication: 2017 May 18.
Autor:
Færch K; Steno Diabetes Center A/S, Niels Steensens Vej 2, 2820, Gentofte, Denmark, krif@steno.dk., Vistisen D, Johansen NB, Jørgensen ME
Publikováno v:
Current diabetes reports [Curr Diab Rep] 2014 Jun; Vol. 14 (6), pp. 493.
Autor:
Jørgensen ME; Steno Diabetes Centre, Gentofte, Denmark. maej@steno.dk, Bjerregaard P, Borch-Johnsen K, Witte D
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2010 Nov; Vol. 95 (11), pp. E333-6. Date of Electronic Publication: 2010 Aug 25.